Bradley Stein is a senior physician policy researcher at the RAND Corporation and an adjunct associate professor of psychiatry at the University of Pittsburgh. A health services and policy researcher with clinical experience working with children and adults with mental health and substance use disorders, Stein's research focuses on understanding and improving care for individuals with mental health and substance use disorders. Stein has worked extensively in the area of school mental health, developing, evaluating, implementing, and disseminating a school-based intervention for students exposed to trauma and violence, as well as implementing a school-based suicide intervention program. He has examined the mental health and substance abuse care of a broad range of Medicaid enrollees, including children and adults with depression, children with ADHD, children with autism, and children receiving psychotropic medications. In recent years a substantial amount of his work has focused on how state and federal policies influence the availability and quality of medication assisted treatment for opioid use disorders, and factors influencing the potentially inappropriate prescribing of opioid analgesics. Stein's recent work also involves using technology to support the dissemination and implementation of effective interventions for traumatized children. Stein received his Ph.D. in health policy and administration from the Pardee RAND Graduate School, and his M.D. and M.P.H. in health services administration from the University of Pittsburgh.
Selected Publications
Leslie DL, Iskandarani K, Dick AW, Mandell DS, Yu H, Velott D, Agbese E, Stein BD, "The effects of Medicaid home and community-based services waivers significantly reduce unmet needs among children with autism spectrum disorder," Medical Care, 2017
Sontag-Padilla L, Woodbridge MW, Mendelsohn J, D’Amico EJ, Chan Osilla K, Jaycox LH, Eberhart NK, Burnam MA, Stein BD., "Mental Health Service Utilization among California Public College and University Students: Who Accesses Resources and Who Doesn’t?" Psychiatric Services, 2016 (forthcoming)
Stein BD, Sorbero M, Dick AW, Pacula RL, Burns RM, Gordon AJ, "Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment," JAMA, 2016
Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, Stein BD., "Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013.," Substance Abuse, 37(1), 2016
Dick AS, Pacula RL, Gordon AJ, Sorbero M, Burns RM, Leslie DL, Stein BD., "Growth in Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.," Health Affairs, 34(6), 2015
Stein BD, Pacula RL, Gordon AL, Burns RM, Leslie DL, Sorbero M, Bauhoff S, Mandell T, Dick AW., "Where is Buprenorphine Dispensed? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.," Millbank Quarterly, 93(9), 2015
